ezetimibe has been researched along with quinoxalines in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 9,887 | 625 | 3,095 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alba, C; Bahinskaya, I; Cerrochi, O; Cypel, M; Dahari, H; Feld, JJ; Hansen, BE; Humar, A; Janssen, HLA; Kamkar, N; Keshavjee, S; Kim, SJ; Kumar, D; Marks, N; McDonald, M; Onofrio, FQ; Pinto Ribeiro, RV; Reichman, TW; Sapisochin, G; Schiff, J; Selzner, M; Singer, LG; Tinckam, K; Waddell, TK; Zahoor, MA | 1 |
1 trial(s) available for ezetimibe and quinoxalines
| Article | Year |
|---|---|
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study.
Topics: Adult; Aged; Anticholesteremic Agents; Antiviral Agents; Benzimidazoles; Canada; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ezetimibe; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Pyrrolidines; Quinoxalines; RNA Viruses; Sulfonamides; Tissue Donors; Transplant Recipients; Transplants; Viral Load | 2020 |